# Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct01803438` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01803438](<https://clinicaltrials.gov/study/NCT01803438>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01803438

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.

## Technical summary

Registry record NCT01803438. Randomized; no masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2019-10-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 220 participants (enrolled count; ClinicalTrials.gov record NCT01803438, source copy `cardio:ctgov-nct01803438-2025-02-13`, retrieved 2026-10-26)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT01803438, source copy `cardio:ctgov-nct01803438-2025-02-13`, retrieved 2026-10-26)
- Primary completion: 2019-10-16 (actual) (ClinicalTrials.gov record NCT01803438, source copy `cardio:ctgov-nct01803438-2025-02-13`, retrieved 2026-10-26)
- Completion: 2020-01-20 (actual) (ClinicalTrials.gov record NCT01803438, source copy `cardio:ctgov-nct01803438-2025-02-13`, retrieved 2026-10-26)
- Countries: Argentina; Australia; Belgium; Croatia; France; Germany; Italy; Netherlands; Norway (ClinicalTrials.gov record NCT01803438, source copy `cardio:ctgov-nct01803438-2025-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01803438-2025-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
- Condition: Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases
- Intervention (Device): cryoballoon ablation system
- Intervention (Drug): Antiarrhythmic Drugs
- Lead sponsor: Medtronic Cardiac Ablation Solutions
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Ablation Solutions (`cardio:org-medtronic-cardiac-ablation-solutions`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms (`cardio:pubmed-34508694`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b3fa4bce45a4ed0b120939735688dc4e20d09ab6ddb4e387d9ea5bd6b375b397
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
